0001209191-17-037112.txt : 20170602 0001209191-17-037112.hdr.sgml : 20170602 20170602151416 ACCESSION NUMBER: 0001209191-17-037112 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170601 FILED AS OF DATE: 20170602 DATE AS OF CHANGE: 20170602 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Insys Therapeutics, Inc. CENTRAL INDEX KEY: 0001516479 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510327886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10220 SOUTH 51ST STREET STREET 2: SUITE 2 CITY: PHOENIX STATE: AZ ZIP: 85044 BUSINESS PHONE: 602-910-2617 MAIL ADDRESS: STREET 1: 10220 SOUTH 51ST STREET STREET 2: SUITE 2 CITY: PHOENIX STATE: AZ ZIP: 85044 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vishnoi Rohit CENTRAL INDEX KEY: 0001706245 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35902 FILM NUMBER: 17887583 MAIL ADDRESS: STREET 1: 1333 SOUTH SPECTRUM BLVD, SUITE 100 CITY: CHANDLER STATE: AZ ZIP: 85286 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-01 0 0001516479 Insys Therapeutics, Inc. INSY 0001706245 Vishnoi Rohit 1333 SOUTH SPECTRUM BLVD, SUITE 100 CHANDLER AZ 85286 1 0 0 0 Common Stock 2017-06-01 4 P 0 4000 14.1438 A 4000 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.14 to $14.145, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. /s/ Darryl Baker, Attorney-in-fact 2017-06-02